Guardant Health, Inc. GH

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $161.01
Market Cap $21.35B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑32.9% YoY
$982.02M
3-Yr CAGR: 29.8%
Net Income
N/A
Net Margin: N/A
Free Cash Flow ↑15.2% YoY
-$233.07M
FCF Yield: -1.09%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: N/A
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (GH)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $0.3M $0.0M $0.0M $-1.8M
FY 2017 $49.8M +15,812.3% $47.1M $-72.2M $-78.9M -4,373.4%
FY 2018 $90.6M +81.9% $89.4M $-72.2M $-92.4M -17.1%
FY 2019 $214.4M +136.5% $213.2M $-47.1M $-65.9M +28.7%
FY 2020 $286.7M +33.8% $282.0M $-103.9M $-140.1M -112.8%
FY 2021 $373.7M +30.3% $371.1M $-209.0M $-284.1M -102.7%
FY 2022 $449.5M +20.3% $447.0M $-309.5M $-386.9M -36.2%
FY 2023 $563.9M +25.5% $336.9M $-325.0M $-345.5M +10.7%
FY 2024 $739.0M +31.0% $449.2M $-239.9M $-274.9M +20.4%
FY 2025 $982.0M +32.9% $633.0M $-184.8M $-233.1M +15.2%
$

Valuation

Market Price $161.01
Market Cap $21.35B
Enterprise Value $22.48B
P/E Ratio N/A
P/B Ratio N/A
FCF Yield -1.09%
Dividend Yield N/A
Shares Outstanding 132,599,899
%

Profitability & Margins

Gross Margin 64.46%
Operating Margin N/A
Net Margin N/A
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) N/A
Asset Turnover 0.49x
Revenue 3-Yr CAGR 29.75%
🛡️

Financial Health & Liquidity

Current Ratio 4.84
Cash Ratio 1.25
Debt / Equity -15.145
Debt / Assets 0.747
Cash & Equivalents $378.20M
Total Debt $1.50B
Book Value / Share $-0.75
💧

Cash Flow Efficiency

Operating Cash Flow -$184.76M
Capital Expenditures (CapEx) $48.31M
Free Cash Flow -$233.07M
OCF / Revenue -18.81%
FCF / Revenue -23.73%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $-0.75
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $2.01B
Total Liabilities $2.11B
Stockholders' Equity -$99.31M
Current Assets $1.47B
Current Liabilities $302.73M